BSGM - BioSig Technologies - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

34.8M

Cash

1.252M

Avg Qtr Burn

-4.901M

Short % of Float

3.92%

Insider Ownership

17.45%

Institutional Own.

6.58%

Qtr Updated

06/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
PURE EP™ (device) Details Medical device, Heart disease	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Merimepodib (MMPD) Details COVID-19	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.